MedPath

Sandoz Hong Kong Limited

🇭🇰Hong Kong, China
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

292

PPB:292

Drug Approvals

SORAFENIB SANDOZ TABLETS 200MG

Approval Date
May 28, 2025
PPB

ABIRATERONE SANDOZ TABLETS 500MG

Approval Date
Apr 14, 2025
PPB

PAZOPANIB SANDOZ TABLETS 200MG

Approval Date
Mar 26, 2025
PPB

BORTEZOMIB SANDOZ POWDER FOR SOLUTION FOR INJECTION 3.5MG

Approval Date
Mar 24, 2025
PPB

DABIGATRAN ETEXILATE SANDOZ CAPSULES 150MG

Approval Date
Feb 21, 2025
PPB

DABIGATRAN ETEXILATE SANDOZ CAPSULES 110MG

Approval Date
Feb 21, 2025
PPB

DABIGATRAN ETEXILATE SANDOZ CAPSULES 75MG

Approval Date
Feb 21, 2025
PPB

SITAGLIPTIN/METFORMIN SANDOZ TABLETS 50MG/500MG

Approval Date
Feb 13, 2025
PPB

SITAGLIPTIN/METFORMIN SANDOZ TABLETS 50MG/1000MG

Approval Date
Feb 13, 2025
PPB

DUTASTERIDE SANDOZ CAPSULES 0.5MG

Approval Date
Feb 11, 2025
PPB
  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 30
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.